Navigation Links
Analysis of the US Neurovascular Intervention Market

London (PRWEB) September 17, 2013

Large Opportunities in Expanding Treatment Options and New Technologies

This research service considers products and companies in the neurovascular intervention market in the United States. This market expects to witness many technology advancements in the next decade. A thorough analysis of revenue forecasts, unit forecasts, technological advances, and pricing are provided for the market’s various segments, including: neurovascular coils, liquid embolics, and stent retrievers markets. Market engineering measurements, drivers, and restraints are covered along with an analysis of the market’s highly competitive landscape. The base year is 2012 and the forecast period extends through 2017.

Executive Summary

  • Total revenue generated by sales of neurovascular intervention market in the US in 2012 was approximately $X million.
  • Revenue in the US neurovascular intervention market is projected to grow at a compound annual growth rate (CAGR) of X percent from 2012 to 2017, reaching $X million in 2017.
  • Currently, the largest market segment is the neurovascular coils market, while the smallest is the liquid embolics market.
  • The segment with the highest CAGR is the stent retriever market, since the first stent retriever in the US was launched in early 2012. More stent retrievers are expected to enter the US market in the coming years.
  • The high growth rate in the stent retriever market is likely to offset the trends in the relatively stable coils and liquid embolics markets, leading to the growth of the overall neurovascular intervention market.
  • There is great uncertainty surrounding the future of the neurovascular coils segment because of emerging flow-diversion devices’ potential to become both a complement and a substitute to coils for aneurysm treatment.
  • The US liquid embolics segment is essentially a monopoly as the Food and Drug Administration (FDA) has placed the only product available under very restricted use for fewer than X patients in the US.
  • Ischemic stroke patients had been previously underserved with only one treatment option; thus, companies are now eager to develop and introduce stent retrievers to the US market with a large patient base and high growth potential.
  • The overall US neurovascular intervention market is very concentrated with only a few large manufacturers because of high barriers to entry, most notably the X(k) clearance required from the US FDA.

CEO’s Perspective

1. Rising ischemic stroke prevalence represents a largely unpenetrated market for solution providers.
2. Shorter recovery time for products like liquid embolics is an attractive option for hospitals looking to cut costs.
3. Growth through mergers and acquisitions is a growing trend to acquire niche technologies.
4. Published data on new clinical trials will motivate physicians and surgeons to use new methods of treatment.
5. Flow diversion devices are a looming threat to the coils market, due to their benefits in wide-neck aneurysms.


  • This market research covers products on the market, products in development, and units, price, and revenue forecasts. Market challenges, including drivers and restraints, are identified and assessed.
  • Units used in the study include:
  • Number of units: This indicates the number of individual units used in surgery.
  • Prices are represented in US dollars. The price is represented as the average selling price (ASP) based on the prices of various units listed by respective manufacturers.
  • Revenue is represented in US dollars. Revenue is a product of the number of units and ASP in a year.
  • ‘N’ for market share represents the revenue for a given market segment.
  • Annual revenue for public companies was derived from annual reports. Revenue for private companies was based on primary interviews.
  • Aneurysm: A bulge in a blood vessel that causes weakening of the vessel wall, which is susceptible to aneurysm rupture leading to a hemorrhagic stroke (bleeding within the brain).
  • Embolization: Placement of a foreign object, such as a neurovascular coil, into the aneurysm to fill in the bulge by inducing blood clot formation to reduce blood flow into the aneurysms and lower the chance of an aneurysm rupture.
  • Acute ischemic stroke (AIS): A stroke that happens when blood flow to the brain is insufficient due to a blockage, for example, by a thrombus (blood clot).
  • Tissue plasminogen activator (tPA): An FDA-approved agent to dissolve the thrombus causing an AIS; must be administered within 3 hours of symptom onset.
  • Primary stroke center (PSC): A facility, usually within a hospital, which specializes in providing stroke-related services, such as diagnosis, treatment, and emergency treatment procedures.

Key Questions this Study will Answer

  • Is the neuro interventional market growing, how long will it continue to grow, and at what rate?
  • What are the primary drivers of market expansion and growth opportunities in large and small segments of the market?
  • Which segments are expanding the most, and which are declining?
  • What type of regulations are affecting the market?
  • Are the products/services offered today meeting customer needs or is there additional development needed?
  • How is the competition in the market? Are some companies poised for more growth than others?

Table of Contents

1. Executive Summary
2. Market Overview
3. Total Neurovascular Intervention Market

  • External Challenges: Drivers and Restraints
  • Forecast and Trends
  • Market Share and Competitive Analysis
4. Neurovascular Coils Segment Breakdown
5. Liquid Embolics Segment Breakdown
6. Stent Retrievers Segment Breakdown
7. The Last Word
8. Appendix

Read the full report:
Analysis of the US Neurovascular Intervention Market

For more information:
Sarah Smith
Research Advisor at
Tel: +44 208 816 85 48

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UC Davis study applies timely cost-effectiveness analysis to state breast cancer screening program
2. Global Diaper Market – Industry Analysis, Size, Share, Growth, Trends and Forecast 2011 - 2017: Transparency Market Research
3. Global Spectrometry Market (Atomic, Molecular and Mass Spectrometry) – Scenario, Trends, Industry Analysis, Size, Share & Forecast 2011 – 2017
4. Global Enteral Feeding Devices Market – Industry Size, Market Share, Trends Analysis, and Forecasts, 2012 – 2018
5. Global Telemedicine and M-Health Convergence Market 2019 Forecast and Analysis in New Research Report at
6. China Orthopedic Instrument Market 2013 Analysis & 2015 Forecasts in New Research Report at
7. Chinese Contract Research Organization Market (CRO) 2013 Analysis in New Research Report at
8. PCMA: New Analysis Shows Alabama Can Reduce Medicaid Pharmacy Waste by $513 Million
9. Overweight and Obesity Market Analysis & Epidemiology Forecasts to 2022 in New Research Report at
10. Cardiovascular Devices Market (Monitoring & Diagnostic) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2011 - 2016
11. Wound Dressings Market – Global Industry Analysis, Size, Share, Trends, and Forecast, 2012 – 2018
Post Your Comments:
(Date:10/10/2015)... ... October 10, 2015 , ... ... is pleased to be recognized by The National Law Journal for inclusion in ... 50 law firms across the United States who obtained the largest awards for ...
(Date:10/9/2015)... Los Angeles, CA (PRWEB) , ... October 09, 2015 , ... ... awareness for breast cancer victims, survivors, and the ongoing effort to find a cure. ... patients another outlet for helping women in need. With their Bra Collection Campaign, Beverly ...
(Date:10/9/2015)... ... October 09, 2015 , ... Advanced Hearing ... Tennessean's eighth annual Toast of Music City, a reader’s choice awards featuring favorite ... and cast votes for their favorite businesses in over 200 categories, including best ...
(Date:10/9/2015)... ... October 09, 2015 , ... The Asthma and Allergy Foundation of America ... Control and Prevention (CDC) to improve the knowledge and skills of underserved adults with ... a project by the CDC and allows AAFA to continue vital efforts to educate ...
(Date:10/9/2015)... ... 09, 2015 , ... MMJ PhytoTech Limited announced that they ... airing 1st QT 2016 via the Discovery Channel. Dates and show times TBA. ... – a global leader in the field of commercializing medicinal grade cannabis. As ...
Breaking Medicine News(10 mins):
... Newsletter for Healthcare ProfessionalsVOORHEES, N.J., March 30 ... urticaria (hives) and angioedema can be challenging, ... a number of immunologic and nonimmunologic mechanisms. ... seemingly identical presentation of angioedema subtypes. It ...
... March 30 One of the longest-term survivors of ... honored today by the Mesothelioma Applied Research Foundation with ... July of 1998, in St. Charles, Missouri, then-42 year-old ... over a few digestive symptoms. Nine days later, he ...
... Indigestion, constipation can be relieved with ancient remedies, ... -- Japanese herbal medicines may help people with ... -- that don,t respond to conventional treatments, a ... these gastrointestinal "motility disorders" don,t work or cause ...
... Headline All-Day FestivalWASHINGTON, March 30 Celebrating its 30th ... National Kidney Foundation is DC,s biggest one-day rock festival ... chili cooks competing for top honors. The event is ... 9:00 p.m. at RFK Stadium Festival Grounds.For the past ...
... and Complex-Event Processing (CEP) Technologies Unified in Rx ... First Choice Professionals, LLC., today announced a partnership ... ), to provide healthcare organizations with advanced technology ... renowned healthcare integration group will combine talents with ...
... Medical Innovations, Inc. (NYSE: IMA ), a global ... at home through the merger of rapid diagnostics and health ... the new C. DIFF QUIK CHEK COMPLETE (TM) rapid ... Clostridium difficile associated disease (CDAD). This follows TECHLAB(R), ...
Cached Medicine News:
(Date:10/8/2015)... Oct. 8, 2015  Allergan plc (NYSE: AGN ... it will hold its R&D Day on November 4, ... – to 1:00 p.m. PT). The company will also ... at 9:00 a.m. ET (6:00 a.m. PT). ... --> Logo - ...
(Date:10/8/2015)... CAMBRIDGE, Mass. , Oct. 8, 2015 /PRNewswire/ ... has awarded approximately $40 million to the Broad ... whole genome sequencing of 20,000 individuals, as well ... sequencing and metabolite profiling. Trans-Omics for ... an initial step toward a larger initiative, which ...
(Date:10/8/2015)... FRANCISCO , Oct. 8, 2015  Nektar Therapeutics ... the Company,s pain and oncology portfolio during an Investor ... - 3:30 p.m. Eastern Time in New ... carcinoma.  Details of the NKTR-214 Phase 1/2 clinical program ... CD122-biased immune-stimulatory cytokine designed to preferentially stimulate the production ...
Breaking Medicine Technology:
... (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David ... be using the Roche LightCycler ® 480 System, a ... gene expression and genetic variation, in advanced cancer research. ... 480 System to support several key areas of research it ...
... 2011 /PRNewswire/ -- Royal Philips Electronics ... States availability of the Ingenia MRI system, the ... Previously available in Europe, Canada and Japan, the ... Food and Drug Administration. Driven by Philips commitment ...
Cached Medicine Technology:
CDIs new improved Implant Stabilizer has super-soft elastic bands with lace trim....
Bras and Breast Support...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test is ... Modified Albumin (IMA®) by measuring the cobalt ... serum sample. First identified in the early ... comes in contact with ischemic tissue in ...
Medicine Products: